Cancers with certain mutations are vulnerable to ferroptosis, a form of iron-dependent cell death.

This form of cell death is called ferroptosis, and certain cancer cells are especially vulnerable to it.

Researchers led by scientists at Memorial Sloan Kettering Cancer Center have now identified fundamentally novel regulatory mechanisms of <i>PTEN</i> function. The findings from two related studies are published in the January 12 issue of <i>Cell</i>.

Researchers have shed light on how an important treatment for early-stage bladder cancer enters cancer cells to eradicate them.

Xuejun Jiang heads a laboratory at the Sloan Kettering Institute, where he continues to help unlock the mysteries of programmed cell death.